Keyword: Kendall Square

The French drugmaker is the latest in a series of European companies to pick the biotech hotspot as their U.S. base.

News of the office opening comes shortly after the French company stepped up its U.S. strategy with a $2.4 billion deal for Shire’s oncology unit.

Cancer and autoimmune startup Cue Biopharma has ended the year with a potentially lucrative new deal with Merck.

Flagship Pioneering’s quiet oncology upstart Torque Therapeutics has filed a $21 million raise as it lands in Kendall Square.

Shire is expanding its innovation play in Cambridge, MA, as it looks to boost its presence in Kendall Square and create a 550,000-square-foot campus focused on rare diseases.

Dermatology pharma LEO has gained the seal of approval for its newly opened Science & Tech Hub in Boston by Her Royal Highness, Crown Princess Mary of Denmark.

A biotech borne out of a JV between Bayer’s new research deals arm and CRISPR Therapeutics will start operations at life sciences hub Kendall Square in Cambridge, MA, next year as looks to get to work on a number of disease areas using the new CRISPR-Cas9 cutting-edge tech.